Identification of p.Gln858* in ATP13A2 in two EOPD patients and presentation of their clinical features
| Autor: | Mehrdad Hashemi, Maryam Malakouti-Nejad, Jian-Bing Fan, Mohammad Rohani, Gholam Ali Shahidi, Brandy Klotzle, Seyed Mehdi Shojaee, Elahe Elahi |
|---|---|
| Rok vydání: | 2014 |
| Předmět: |
Adult
Male Pediatrics medicine.medical_specialty Biology Iran Young Adult medicine Humans Disease-causing Mutation Genetic Testing Allele Cognitive decline Dystonia Genetics General Neuroscience Haplotype Homozygote Chromosome Mapping Parkinson Disease Middle Aged medicine.disease Disease gene identification LRRK2 nervous system diseases Proton-Translocating ATPases Dyskinesia Mutation Female medicine.symptom |
| Zdroj: | Neuroscience letters. 577 |
| ISSN: | 1872-7972 |
| Popis: | We present results of homozygosity mapping in two siblings affected with early onset Parkinson's disease (EOPD) and mutation screening of ATP13A2 in these and other Iranian EOPD patients. Genome-wide SNP homozygosity analysis revealed linkage to a locus that included ATP13A2, and sequencing of the gene revealed a novel p.Gln858*-causing mutation in the homozygous state in the siblings. Sequencing of the gene in seven other unrelated EOPD patients previously shown not to have mutations in PRKN, DJ-1, PINK1, and LRRK2 identified the same homozygous p. Gln858*-causing mutation in another patient. Haplotype analysis revealed that two alleles harboring the mutation were not identical by decent. The variation identified represents the 13th known disease causing mutation in ATP13A2. The clinical features of the patients who harbored the mutation are compared to those of previously reported patients with mutations in ATP13A2. Bradykinesia and rigidity, but not tremor, were reported in nearly all the patients. l-dopa administration, though initially effective, usually caused dyskinesia upon prolonged usage. Eye movement abnormalities including saccades and supranuclear gaze palsy, were almost always observed. Dystonia and bulbar anomalies were common but more variable manifestations. Although a degree of cognitive decline was found in most of the patients, the decline was often mild and absent in one patient. Age at onset of symptoms was usually in the second decade of life, and sometimes in the third decade. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect